Singulair - News Articles

PharmaTimes | Industry News | World News | Schering-Plough stunned by FDA's rejection of Bridion
Monday, August 04, 2008
Pharma Times (subscription), UK -
Schering-Plough has suffered a major blow with the news that US regulators have rejected its anaesthesia compound sugammadex, just months after being recommended for approval. The US Food and Drug Administration has issued a ‘not-approvable’ letter for Bridion (sugammadex), an ...
FDA unexpectedly rejects Schering anesthesia drug - Boston.com
Aug 2, 2008
Boston Globe, United States -
NEW YORK (Reuters) - Schering-Plough Corp said on Friday US regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts and was unanimously recommended by a federal advisory panel. ...
FDA rejects Schering-Plough's anesthesia-reversing drug, citing allergic reactions
Aug 2, 2008
Minneapolis Star Tribune, MN -
By MATTHEW PERRONE , AP WASHINGTON - Government regulators dealt a major setback to Schering-Plough Corp., rejecting a highly anticipated drug designed to help patients recover from anesthesia. The Food and Drug Administration notified the company Thursday that it will not ...
Science/AAAS | Science Magazine: Sign In
Jul 31, 2008
Science Magazine (subscription) -
Neuroimaging, high-tech materials, new asthma meds, detection-eluding drugs, thermoregulation--will all these make athletes stronger and faster at the 2008 ...
INTERNATIONAL OLYMPIC COMMITTEE - NEWS
Sunday, August 03, 2008
Olympic -
Athletes participating in the Beijing 2008 Olympic Games will donate sporting clothes for refugees in Asia. The IOC and the United Nations High Commissioner for Refugees explains: "Refugee youth have often suffered terribly and witnessed war first hand. Some refugees are born in ...
California Job Journal
Saturday, August 02, 2008
California Job Journal, CA -
Review Major depression, xanax. Xenical hgh phentermine online no prescription pharmacy discounter! In some we invite you to tell your life! ...
California Job Journal
Sunday, August 03, 2008
California Job Journal, CA -
It is not generic ambien at our pharmacy. Ambien is indicated for for sale. Bextra outweighed Bextra be monitored during treatment. ...
Science/AAAS | Science Magazine: Sign In
Jul 31, 2008
Science Magazine (subscription) -
Neuroimaging, high-tech materials, new asthma meds, detection-eluding drugs, thermoregulation--will all these make athletes stronger and faster at the 2008 ...
Blue Sky Feels A Little Different In Beijing : NPR
Friday, August 01, 2008
NPR -
Day to Day, August 1, 2008 · Air quality in Beijing has been improving steadily since July 26, says University of Rhode Island atmospheric chemist Kenneth Rahn. Rahn, who plots the daily air quality in Beijing, decodes "blue sky days" and other measures of air ...
domain-b.com : US FDA rejects Schering-Plough's post-surgery drug Sugammadex
Friday, August 01, 2008
domain-B, India -
Mumbai: The US Food and Drug Administration (FDA) has rejected Schering-Plough Corporatin's new anesthesia product Sugammadex, saying the drug designed to undo the affects of muscle relaxants after surgeries, was  non-approvable. FDA has issued a ''non-approvable" letter for ...
RTTNews - Breaking News, financial breaking News, Positive EPS Surprises, Stock research ....
Friday, August 01, 2008
RTT News, NY -
(RTTNews) - Global health care company Schering-Plough Corp. (SGP: News, Chart, Quote ) said Friday that the US Food and Drug Administration issued a "not-approvable" letter for sugammadex sodium injection for the reversal of muscle relaxation during general anesthesia. Thomas Koestler, Executive ...
Abkhazia Institute for Social and Economic Research - EU OKs Drug to Reverse Neuromuscular Blockade
Friday, August 01, 2008
Abkhazia, CA -
European regulators have approved a breakthrough new medication to help patients emerge far more quickly from anesthesia than existing treatments, the drug's maker Schering-Plough Corp said on Tuesday. The drug, called Bridion, was approved by the European Commission, ...
U.S. FDA Issues Action Letter for Sugammadex
Friday, August 01, 2008
Earthtimes (press release), UK -
KENILWORTH, NJ , Aug. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the US Food and Drug Administration (FDA) has ...
RTTNews - Latest Earnings,Upcoming Earnings, Pos Pre Announcements, Pos Pre Announcements , Positive Surprises, Negative Surprises, Hot Stocks, Stock Split Calendar, Stock Buybacks, Dividends, Negative, Positive PreAnnouncements,Surprises ....
Friday, August 01, 2008
RTT News, NY -
(RTTNews) - Schering-Plough (SGP: News, Chart, Quote ) fell in pre-market trading, down nearly 8%. The drop came after the company received a not-approvable letter for sugammadex sodium injection for the reversal of muscle relaxation during general anesthesia. It is to be noted ...
FDA Rejects Schering-Plough Anethesia Drug // Pharmalot
Friday, August 01, 2008
Pharmalot, NJ -
By Ed Silverman // August 1st, 2008 // 10:45 am The rejection of Bridion, a drug developed to reverse the effects of anesthesia, is the latest setback for the drugmaker, which is still reeling over the controversy and subsequent loss in revenue from its Vytorin cholesterol pill. ...
FDA Issues Action Letter for Sugammadex
Friday, August 01, 2008
NJBIZ, NJ -
Kenilworth-based Schering-Plough Corp. (NYSE: SGP) said today that the US Food and Drug Administration has issued a "not-approvable" letter for sugammadex, ...
EU OKs Schering-Plough Corporation's "Breakthrough" New Anesthesia Drug
Friday, August 01, 2008
Lifescience-online, Switzerland -
Schering-Plough Corporation today announced that the European Commission (EC) has approved BRIDION(R) (sugammadex) injection, the first and only selective relaxant binding agent (SRBA), is the first major pharmaceutical advance in the field of anesthesia in two decades. It ...
Ahead of the Bell: Schering-Plough - Forbes.com
Friday, August 01, 2008
Forbes, NY -
AP 08.01.08, 8:06 AM ET Shares of drug maker Schering-Plough Corp. fell in premarket trading Friday following the Food and Drug Administration's surprise ...
Premarket roundup:Schering-Plough,Urban Outfitters
Friday, August 01, 2008
CNNMoney.com -
NEW YORK (AP)_ Shares of drug maker Schering-Plough Corp. fell in premarket trading Friday following the Food and Drug Administration's surprise rejection ...
Free Preview - WSJ.com
Friday, August 01, 2008
Wall Street Journal -
By KEVIN KINGSBURY The Food and Drug Administration issued a non-approvable letter to Schering-Plough Corp. for its drug designed to undo the affects of ...

Pages: Previous   1   2   3   4   5   6   7   ...   Next

AddThis Social Bookmark Button

Need A Singulair Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Need A Singulair Lawyer?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Singulair Case - Submit Your Information Below

Do you need legal assistance with your Singulair case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Singulair Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.